In North America, key drivers include adoption of HPMCAS in the pharmaceutical industry, policies supporting the use of HPMCAS in food and beverages, and investments in research and development. In Europe, key drivers include regulatory support, infrastructure, and ecosystem maturity. In Asia Pacific, key drivers include adoption of HPMCAS in the pharmaceutical industry, policies supporting the use of HPMCAS in food and beverages, and investments in research and development. In Latin America, key drivers include demographics, infrastructure, and ecosystem maturity. In Middle East & Africa, key drivers include policies supporting the use of HPMCAS in food and beverages, investments in research and development, and regional forecast indicating growth opportunities.